bell
The current prices are delayed by 15 mins, login to check live prices.
Sotac Pharmaceuticals Ltd share price logo

Sotac Pharmaceuticals Ltd

(SOTAC)

₹109.150.32%

as on 04:01PM, 24 Dec 2024

Overview
News
Financials
Q2 2024 Results
Technicals

Sotac Pharmaceuticals Ltd Performance

  • Day's High

    ₹109.15
    Day's Price Range
    ₹110.1
  • 52 Week's Low

    52 Week's High

    ₹87.1
    52-Week Price Range
    ₹202.8
1 Month Return-4.78 %
3 Month Return-23.16 %
1 Year Return-7.2 %
Previous Close₹109.50
Open₹110.10
Volume0.00
Upper Circuit-
Lower Circuit-
Market Cap₹121.00Cr

Sotac Pharmaceuticals Ltd Key Statistics

P/E Ratio16.73
PEG Ratio1.27
Market Cap₹887.00 Cr
P/B Ratio21.77
EPS17.09
Dividend Yield0
SectorPharmaceuticals
ROE38.26

Sotac Pharmaceuticals Ltd Peer Comparison

Company
Analyst ViewMarket Cap5 Year CAGRDebt to Asset RatioNet ProfitYearly Revenue
NA₹887.00 Cr264.92%0.91₹55 Cr₹575 Cr
NA₹2,407.31 Cr159.02%0.62₹43 Cr₹381 Cr
NA₹930.38 Cr681.88%0.65₹23 Cr₹307 Cr
NA₹519.70 Cr31.31%0.56₹13 Cr₹154 Cr
NA₹760.23 Cr46.35%0.52NANA

About Sotac Pharmaceuticals Ltd

Sotac Pharmaceuticals Limited is a part of the Gujarat based SOTAC Group, offering a range of products such as tablets, capsules, oral liquids, and external preparations. Their therapeutic portfolio includes options for treating ailments such as diabetes, psychotics, vitamins, minerals, cold, allergies, ulcers, and more. They started off as a Partnership Firm in October 2015 and have since then evolved into a Public Limited Company. Their installed capacity for manufacturing is 90 crore tables and 14 crore capsules per year. In 2022, they acquired two subsidiary companies and started a new venture called SOTAC Lifescience Private Limited, raising 51 percent of total paid-up capital. They are planning to come out with a Initial Public Offer consisting of up to 3 million equity shares through a fresh issue.

Share Price: ₹109.15 per share as on 24 Dec, 2024 04:01 PM
Market Capitalisation: ₹121.00Cr as of today
Revenue: ₹27.35Cr as on September 2024 (Q3 24)
Net Profit: ₹0.42Cr as on September 2024 (Q3 24)
Listing date: 13 Apr, 2023
Chairperson Name: Sharadkumar Dashrathbhai Patel
OrganisationSotac Pharmaceuticals Ltd
Headquarters
IndustryPharmaceuticals
E-voting on sharesClick here to vote

Key events for Sotac Pharmaceuticals Ltd

  • Sotac Pharmaceuticals' High P/E Ratio Raises Concerns - 28 Jun, 2024

    Sotac Pharmaceuticals has a high P/E ratio of 39.7x, which may be unjustified despite strong recent earnings growth of 37%. Shareholders may face disappointment if the P/E falls to levels more in line with recent growth rates.
  • Sotac Pharmaceuticals Receives Order Worth Rs. 17.13 Crores - 26 Jun, 2024

    Shares of Sotac Pharmaceuticals surged by 20% after receiving an order worth Rs. 17.13 crores from Rajasthan Medical Services Corporation Limited. The company's revenue increased by 35% and net profits magnified by 100% in FY23-24. Key customers include Cadila Pharma, Intas Pharma, and Eris Lifesciences. Promoters hold a stake of 72.85%, while FIIs hold 8.99% of the shares.
  • Sotac Pharmaceuticals' Financial Prospects Look Decent Despite Recent Stock Weakness - 05 Jun, 2024

    Despite Sotac Pharmaceuticals' stock being down 33% over the past three months, its key financial indicators look decent. The company's ROE suggests that the stock could potentially rise in the long-term given more resilient long-term fundamentals.

Insights on Sotac Pharmaceuticals Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 25.5 Cr → 27.8 Cr (in ₹), with an average increase of 8.3% per quarter

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 18.16% to 18.27% in Sep 2024 quarter

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 72.85% of holdings in Sep 2024 quarter

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 8.99% to 8.88% in Sep 2024 quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 3 months, SOTAC stock has moved down by -23.2%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 3 quarters, 1.64 Cr → 0.46 Cr (in ₹), with an average decrease of 39.9% per quarter

Sotac Pharmaceuticals Ltd Financials

Value in ₹ crore
DetailsQ'3 23Q'4 23Q'1 24Q'2 24Q'3 24
Revenue₹26.67Cr (-)₹25.74Cr (↓3.49%)₹26.45Cr (↑2.76%)₹25.25Cr (↓4.54%)₹27.35Cr (↑8.32%)
Net Income₹0.21Cr (-)₹0.88Cr (↑319.05%)₹1.51Cr (↑71.59%)₹1.35Cr (↓10.60%)₹0.42Cr (↓68.89%)
Net Profit Margin0.79% (-)3.42% (↑332.91%)5.71% (↑66.96%)5.35% (↓6.30%)1.54% (↓71.21%)
Value in ₹ crore
Details2020202120222023
Total Assets₹21.36Cr (-)₹22.50Cr (↑5.34%)₹36.34Cr (↑61.51%)₹54.95Cr (↑51.21%)
Total Liabilities₹17.67Cr (-)₹17.69Cr (↑0.11%)₹29.24Cr (↑65.29%)₹33.96Cr (↑16.14%)
Value in ₹ crore
Details20202021202220232024
Operating Cash Flow- (-)₹2.22Cr (-)₹3.58Cr (↑61.26%)₹8.54Cr (↑138.55%)- (↓100.00%)

Sotac Pharmaceuticals Ltd Shareholding Pattern

InvestorsHoldings %FY Quarter3M change
Promoter Holdings
72.85%
0.00
Foreign Institutions
8.88%
-1.21
Mutual Funds
0%
0.00
Retail Investors
18.27%
0.60
Others
0%
0.00

Sotac Pharmaceuticals Ltd Key Indicators

Details20222023
Return On Equity %76.9132.04
Details20212023
Return On Assets %-10.535.24
Details2024
Book Value Per Share (₹)40.96
Details2024
Earning Per Share (₹)3.24

Sotac Pharmaceuticals Ltd Valuation

Sotac Pharmaceuticals Ltd in the last 5 years

  • Overview

  • Trends

Lowest (13.14x)

April 24, 2023

Today (27.04x)

December 20, 2024

Industry (56.39x)

December 20, 2024

Highest (44.90x)

July 16, 2024

LowHigh

Sotac Pharmaceuticals Ltd Earnings and Dividends

  • Sotac Pharmaceuticals Ltd Earnings Results

    Sotac Pharmaceuticals Ltd’s net profit fell -29.23% since last year same period to ₹0.46Cr in the Q2 2024-2025. On a quarterly growth basis, Sotac Pharmaceuticals Ltd has generated -68.28% fall in its net profits since last 3-months.

    Read More about Earnings Results

Sotac Pharmaceuticals Ltd Technicals Summary

Bearish

Neutral

Bullish

Bearish

Sotac Pharmaceuticals Ltd is currently in a Bearish trading position according to technical analysis indicators.

FAQs on Sotac Pharmaceuticals Ltd

  • Get a PAN card.
  • Open a Demat account.
  • Open a Trading account.
  • Link your Demat account to your Trading account.
  • Fund your Trading account.
  • Place an order to buy Sotac Pharmaceuticals Ltd shares.

Sotac Pharmaceuticals Ltd (SOTAC) share price today is ₹109.15

Sotac Pharmaceuticals Ltd is listed on NSE

Sotac Pharmaceuticals Ltd is not listed on BSE

  • Today’s highest price of Sotac Pharmaceuticals Ltd is ₹110.1.
  • Today’s lowest price of Sotac Pharmaceuticals Ltd is ₹109.15.

PE Ratio of Sotac Pharmaceuticals Ltd is 27.04

PE ratio = Sotac Pharmaceuticals Ltd Market price per share / Sotac Pharmaceuticals Ltd Earnings per share

Today’s traded volume of Sotac Pharmaceuticals Ltd(SOTAC) is 0.00.

Today’s market capitalisation of Sotac Pharmaceuticals Ltd(SOTAC) is ₹121Cr.

Sotac Pharmaceuticals Ltd(SOTACPrice
52 Week High
₹202.8
52 Week Low
₹87.1

Sotac Pharmaceuticals Ltd(SOTAC) share price is ₹109.15. It is down -46.18% from its 52 Week High price of ₹202.8

Sotac Pharmaceuticals Ltd(SOTAC) share price is ₹109.15. It is up 25.32% from its 52 Week Low price of ₹87.1

Sotac Pharmaceuticals Ltd(SOTACReturns
1 Day Returns
-0.35%
1 Month Returns
-4.78%
3 Month Returns
-23.16%
1 Year Returns
-7.2%